Results 171 to 180 of about 114,540 (260)

Colorectal Cancer in Inflammatory Bowel Disease: How to Minimize the Risk. [PDF]

open access: yesCancers (Basel)
Nassera B   +8 more
europepmc   +1 more source

Clinician perspectives on infusion site‐of‐care shifts in pediatric inflammatory bowel disease: An anonymous national web‐based survey

open access: yesJPGN Reports, EarlyView.
Abstract Commercial payers and pharmacy benefit managers use site‐of‐care and specialty drug distribution policies (including white bagging and brown bagging) that can redirect infusion‐based biologic therapies from hospital outpatient departments to alternate settings.
Brad Pasternak
wiley   +1 more source

Direct clinician–pathologist multidisciplinary review and diagnostic revision in children with gastrointestinal disorders

open access: yesJPGN Reports, EarlyView.
Abstract Accurate pediatric gastrointestinal (GI) diagnosis often depends on integrating clinical, endoscopic, and histopathologic information. We evaluated the impact of weekly face‐to‐face multidisciplinary team (MDT) meetings on diagnosis in children undergoing endoscopy or liver biopsy at a tertiary center.
Emma Dahl   +4 more
wiley   +1 more source

Adverse arrhythmia-related outcomes after catheter ablation in patients with inflammatory bowel disease: a nationwide propensity score-matched cohort study. [PDF]

open access: yesEur Heart J Open
Ebrahimi R   +9 more
europepmc   +1 more source

Insurance IQ: Demystifying health insurance for young people with inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
ABSTRACT Many adolescents and young adults with inflammatory bowel disease (AYA‐IBD) lack essential health insurance knowledge. We evaluated an electronic health record (EHR)–based educational intervention to improve insurance literacy. From January to August 2025, AYA‐IBD who had completed a health insurance knowledge assessment and had an upcoming ...
Laura Gilligan, Jeannie S. Huang
wiley   +1 more source

Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance

open access: yesJPGN Reports, EarlyView.
Abstract Janus kinase inhibitors (JAKi) are increasingly used for refractory inflammatory bowel disease (IBD) in pediatric patients but are associated with significant dermatologic adverse effects. Acneiform eruptions have been reported in up to 30% of adults, with a greater incidence suspected in adolescents.
Tina H. Tran   +5 more
wiley   +1 more source

Prevalence of inflammatory bowel disease across states: estimates based on claims database. [PDF]

open access: yesInflamm Bowel Dis
Kang H   +6 more
europepmc   +1 more source

Human immunodeficiency virus infection mimicking very early onset inflammatory bowel disease [PDF]

open access: yesJPGN Rep
Abstract Very early onset inflammatory bowel disease (VEO‐IBD), defined as diagnosis before 6 years of age, is often associated with immune dysregulation and monogenic etiologies; however, infectious mimics may be overlooked in low‐prevalence regions. We report a 4‐year‐old male with poor weight gain, intermittent diarrhea, elevated fecal calprotectin,
Abi Radi Abou Jaoudeh R, Sauer C, Oh T.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy